Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Vaso-Occlusive Crises × maltodextrin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Colonic Neoplasms 2 Vaso-Occlusive Crises 1 Seaweed Associated Changes in Healthy Subjects 1 Prostatic Neoplasms 1 Proctitis 1 Polycystic Ovary Syndrome 1 Neoplasms 1 Insulin Resistance 1 Hyperandrogenism 1 Head and Neck Neoplasms 1 Glucose Intolerance 1 Diarrhea 1 Colorectal Neoplasms 1 Colonic Polyps 1 Anovulation 1 Anemia, Sickle Cell 1

Interventions

maltodextrin 1 Glutamine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01179217 2020-08-19

A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia

Emmaus Medical, Inc.

Phase 3 Completed

230 enrolled 19 charts 1 FDA

Classical hematology

Vaso-Occlusive Crises, Anemia, Sickle Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡